Annagür, Bilge BurçakBez, Yasin2020-03-262020-03-262012Annagür, B. B., Bez, Y., (2012). Varenicline-Induced Psychotic Depressive Episode in a Patient with Bipolar Disorder. Therapeutic Advances in Psychopharmacology, 2(1), 35-37. Doi: 10.1177/20451253114301111398-5647https://hdl.handle.net/20.500.12395/286165th Biennial Conference of the International-Society-for-Bipolar-Disorders -- MAR 14-17, 2012 -- Istanbul, TURKEYVarenicline is a relatively novel medication for smoking cessation. Increased neuropsychiatric symptoms have been reported with its use and it is listed among drugs with a black box warning. History of a psychiatric diagnosis is suggested to be a vulnerability factor for the development of some psychiatric side effects with its use. However, empirical evidence to support this point is very limited. Here, we report the case of a bipolar patient who developed a depressive episode with psychotic features immediately after varenicline use. Clinicians should be careful about the varenicline-induced neuropsychiatric effects. Healthcare professionals can provide an important role in helping to prevent and manage worsening psychiatric symptoms.eninfo:eu-repo/semantics/openAccessBipolar DisorderSide EffectVareniclineConference Object213537WOS:000301531000133Q1